Dr Tom Bird, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with gastric cancer.  We cover scenarios including both operable gastric cancer and those with recurrent and de-novo metastatic cancer including systemic agents and palliative radiotherapy.  This podcast is an overview of the current oncology treatment of gastric cancer at registrar level and is aimed at those training in oncology in the UK. Your host is Dr Alison...

This is the second interview with Dr Tom Strawson-Smith, Consultant Clinical Oncologist, at Bristol Haematology and Oncology Centre, UK, concluding the overview of how to manage colorectal cancer.  He discusses how he treats people who have metastatic colorectal cancer, both widely metastatic and those with oligo-metastatic disease, focusing on the use of systemic treatments.  This podcast is an overview of current oncology treatment of metastatic colorectal cancer at registrar level. Your...

Dr Tom Strawson-Smith, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, UK, discusses how he treats people with initial colorectal cancer.  We cover chemotherapy use in colon cancer, chemo-radiotherapy in rectal cancer including how to plan the radiotherapy, DPD deficiency and ongoing areas of research.  This podcast is an overview of the current oncology treatment of intial CRC at registrar level. Your host is Dr Alison Cameron, Consultant Clinical Oncologist,...

Dr Axel Walther, Consultant Medical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with recurrent ovarian cancer.  He also recaps on the use of PARP inhibitors in initial advanced ovarian cancer.  He is a great font of knowledge on ovarian cancer and the trials that underpin the treatment options, so this podcast will be a very useful overview of the UK current treatment paradigms at registrar level. Your host is Dr Alison Cameron, Consultant...

Dr Axel Walter, Consultant Medical Oncologist at Bristol Haematology and Oncology Center, kicks off the series about how to manage ovarian cancer.  He discusses in depth the staging system and how women with initial ovarian cancer should be treated, including both those with stage 1 and stage 3 disease.  This includes an explanation regarding BRCA and HRD (homologous recombination deficiency) testing and treatment with adjuvant PARP inhibitors. Your host is Dr Alison Cameron, Bristol, UK.

Dr Charlie Comins, Consultant Clinical Oncologist at the Bristol Haematology and Oncology Centre, UK, joins us for the final podcast in the breast cancer series.  He discusses how to treat a woman with metastatic triple negative breast cancer including use of new immunotherapies, if she was diagnosed after adjuvant chemotherapy or de novo metastatic disease. Your host is Dr Alison Cameron,Bristol, UK.

Dr Charlie Comins, Consultant Clinical Oncologist at Bristol Haematology and Oncology Center, UK joins us again to discuss how to manage the care of a woman with metastatic HER2+ breast cancer, including the management of her brain metastases,  multiple lines of potential treatments and if she was diagnosed post adjuvant therapy, during adjuvant therapy or at inital diagnosis of breast cancer. Your host is Dr Alison Cameron, Bristol, UK.

Dr Comins, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, specialist in breast and lung cancer, explains how he approaches the management of a woman with ER positive breast cancer, including how to treat bone metastases. Your host is Dr Alison Cameron, Clinical Oncologist, Bristol, UK. This series is a teaching resource aimed at oncology registrars in UK, though is applicable internationally. For more information please go to www.ace-rt.com/learn

Interviewee today is Miss Michelle Mullan, Consultant Oncoplastic Breast Surgeon in Bristol. She provides an excellent overview of surgery for early breast cancer for an oncologist. This podcast is aimed at those training in oncology and covers surgery to the breast, axilla and for recurrence. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK. www.ace-rt.com/learn

This is the fourth and final interview with Dr Jenner regarding the non-surgical treatment of early breast cancer. All aspects of management are covered within these four podcasts, with this final short podcast covering triple negative breast cancer, who to refer for genetic analysis and the treatment options for those who are BRCA positive.

This is the third interview with Dr Jenner, specialist in breast cancer treatment in Bristol, UK. This podcast is aimed at those training in clinical oncology and focuses on the role of radiotherapy in early breast cancer. Dr Jenner discusses the practicalities of radiotherapy planning (to the breast and local lymph nodes), the dose including the results from the fast forward study, and the rationale for radiotherapy. Your host is Dr Alison Cameron, Clinical Oncologist, Bristol, UK....

This is the second interview with Dr Abi Jenner, specialist in breast cancer in Bristol, UK, regarding the treatment of early breast cancer.  This podcast is aimed at those training in oncology and focuses on the treatment of those with HER-2 positive, ER/PR negative early breast cancer.  Dr Jenner discusses how she would treat both a woman with a larger tumour requiring neo-adjuvant chemotherapy/targeted therapy, and a woman with a smaller tumour initially treated with surgery. Your host is...

Welcome to The Bristol Oncology Podcasts. These podcasts are aimed at those training to become oncologists, providing an overview of how to treat people with cancer. The first series covers the treatment of breast and ovarian cancer. In this episode, Dr Alison Cameron is host with Dr Abigail Jenner the specialist sharing her expertise regarding the management of a 58 year old woman with ER/PR+, HER-2- breast cancer covering the role of chemotherapy, hormonal therapy and...